• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两性霉素B眼膏治疗真菌性角膜溃疡

Treatment of fungal corneal ulcers with amphotericin B ointment.

作者信息

Hirose H, Terasaki H, Awaya S, Yasuma T

机构信息

Department of Ophthalmology, Nagoya University, School of Medicine, Japan.

出版信息

Am J Ophthalmol. 1997 Dec;124(6):836-8. doi: 10.1016/s0002-9394(14)71701-5.

DOI:10.1016/s0002-9394(14)71701-5
PMID:9402830
Abstract

PURPOSE

To report two patients with severe fungal corneal ulcers who were treated successfully with topical amphotericin B ointment.

METHODS

Two eyes of two patients developed corneal ulcers and hypopyon after corneal foreign body removal. Aspergillus fumigatus and Fusarium solani were isolated in Patients 1 and 2, respectively. By antifungal susceptibility testing, amphotericin B was shown to have the lowest minimal inhibitory concentration.

RESULT

Topical administration of amphotericin B ointment resulted in dramatic improvement in fungal corneal ulcers.

CONCLUSIONS

Antifungal susceptibility tests may aid with selection of antifungal agents. Amphotericin B ointment is one of the promising therapies for keratomycosis caused by antimycotic-resistant fungi.

摘要

目的

报告两例严重真菌性角膜溃疡患者,经局部应用两性霉素B眼膏成功治愈。

方法

两名患者在角膜异物取出术后均出现角膜溃疡和前房积脓。分别从患者1和患者2中分离出烟曲霉和茄病镰刀菌。通过抗真菌药敏试验,两性霉素B显示出最低的最低抑菌浓度。

结果

局部应用两性霉素B眼膏使真菌性角膜溃疡得到显著改善。

结论

抗真菌药敏试验有助于抗真菌药物的选择。两性霉素B眼膏是治疗由抗真菌耐药真菌引起的角膜真菌病的有前景的治疗方法之一。

相似文献

1
Treatment of fungal corneal ulcers with amphotericin B ointment.两性霉素B眼膏治疗真菌性角膜溃疡
Am J Ophthalmol. 1997 Dec;124(6):836-8. doi: 10.1016/s0002-9394(14)71701-5.
2
The use of collagen shields impregnated with amphotericin B to treat Aspergillus keratomycosis.使用浸渍两性霉素B的胶原盾治疗曲霉性角膜真菌病。
CLAO J. 1995 Oct;21(4):252-5.
3
Fungal keratitis after laser in situ keratomileusis: a case report.准分子原位角膜磨镶术后真菌性角膜炎:一例报告
Cornea. 2000 Mar;19(2):236-7. doi: 10.1097/00003226-200003000-00019.
4
Efficacy of topical caspofungin in experimental fusarium keratitis.局部应用卡泊芬净治疗实验性镰刀菌角膜炎的疗效
Cornea. 2007 Jul;26(6):726-8. doi: 10.1097/ICO.0b013e3180553b9d.
5
Efficacy of intracameral amphotericin B injection in the management of refractory keratomycosis and endophthalmitis.前房内注射两性霉素B治疗难治性角膜真菌病和眼内炎的疗效
Cornea. 2007 May;26(4):398-402. doi: 10.1097/ICO.0b013e318030767e.
6
Treatment of severe fungal keratitis with subconjunctival amphotericin B.结膜下注射两性霉素 B 治疗严重真菌性角膜炎。
Cornea. 2011 May;30(5):608-11. doi: 10.1097/ICO.0b013e3181fb826d.
7
Intracameral amphotericin B: initial experience in severe keratomycosis.前房内注射两性霉素B:重度角膜真菌病的初步经验
Cornea. 2001 Oct;20(7):715-9. doi: 10.1097/00003226-200110000-00009.
8
Oral fluconazole therapy for keratomycosis.口服氟康唑治疗角膜真菌病。
Acta Ophthalmol (Copenh). 1994 Dec;72(6):765-7. doi: 10.1111/j.1755-3768.1994.tb04697.x.
9
Black corneal ulcer.黑色角膜溃疡
Cornea. 1997 Sep;16(5):590-1.
10
Topical amphotericin B and subconjunctival injection of fluconazole (combination therapy) versus topical amphotericin B (monotherapy) in treatment of keratomycosis.局部应用两性霉素 B 和球结膜下注射氟康唑(联合治疗)与局部应用两性霉素 B(单一治疗)治疗真菌性角膜炎的比较。
J Ocul Pharmacol Ther. 2010 Jun;26(3):281-5. doi: 10.1089/jop.2010.0005.

引用本文的文献

1
Evaluation of liposomal amphotericin B for the treatment of fungal keratitis in a tertiary eye care hospital.评价两性霉素 B 脂质体治疗三级眼科医院真菌性角膜炎的效果。
Indian J Ophthalmol. 2023 Feb;71(2):518-523. doi: 10.4103/ijo.IJO_1474_22.
2
Therapeutic efficacy of intracameral amphotericin B injection for 60 patients with keratomycosis.前房内注射两性霉素B治疗60例角膜真菌病的疗效
Int J Ophthalmol. 2010;3(3):257-60. doi: 10.3980/j.issn.2222-3959.2010.03.18. Epub 2010 Sep 18.
3
Current perspectives on ophthalmic mycoses.眼部真菌病的当前观点
Clin Microbiol Rev. 2003 Oct;16(4):730-97. doi: 10.1128/CMR.16.4.730-797.2003.